New Drug Shows Promise for Women with Sexual Dysfunction

Armen Hareyan's picture

Women's sexual dysfunction

A study in the July issue of The Journal of Sexual Medicine reports that bremelanotide, originally developed for the treatment of erectile dysfunction, has the potential to positively affect desire and arousal in women with female sexual arousal disorder (FSAD).

Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.